Kaiqian Zhou

2.4k total citations
35 papers, 850 citations indexed

About

Kaiqian Zhou is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Kaiqian Zhou has authored 35 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Oncology and 9 papers in Hepatology. Recurrent topics in Kaiqian Zhou's work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and MicroRNA in disease regulation (4 papers). Kaiqian Zhou is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and MicroRNA in disease regulation (4 papers). Kaiqian Zhou collaborates with scholars based in China, Ethiopia and United States. Kaiqian Zhou's co-authors include Jia Fan, Jian Zhou, Zhizheng Wu, Minshan Jiang, Yun‐Fan Sun, Xin‐Rong Yang, Ya Cao, Bo Hu, Jie Hu and Hua Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Journal of Hepatology.

In The Last Decade

Kaiqian Zhou

34 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaiqian Zhou China 16 305 268 222 210 161 35 850
Ronald Chan Hong Kong 18 275 0.9× 203 0.8× 239 1.1× 113 0.5× 119 0.7× 54 1.2k
Zijie Wang China 19 304 1.0× 134 0.5× 103 0.5× 70 0.3× 44 0.3× 72 911
Chul Koo Cho South Korea 23 126 0.4× 149 0.6× 253 1.1× 329 1.6× 710 4.4× 43 1.7k
Huaichao Luo China 13 305 1.0× 190 0.7× 132 0.6× 47 0.2× 29 0.2× 58 619
Sheng Li China 20 235 0.8× 160 0.6× 425 1.9× 52 0.2× 46 0.3× 57 786
Jin Zhou China 16 245 0.8× 217 0.8× 162 0.7× 318 1.5× 15 0.1× 57 969
Fuxing Zhao China 14 251 0.8× 151 0.6× 542 2.4× 52 0.2× 30 0.2× 56 948
Zhiqiao Zhang China 17 239 0.8× 195 0.7× 137 0.6× 99 0.5× 71 0.4× 45 760
Xiao Hu China 12 57 0.2× 37 0.1× 308 1.4× 253 1.2× 20 0.1× 40 631
Panagiota Ravazoula Greece 18 239 0.8× 96 0.4× 197 0.9× 139 0.7× 39 0.2× 68 890

Countries citing papers authored by Kaiqian Zhou

Since Specialization
Citations

This map shows the geographic impact of Kaiqian Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaiqian Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaiqian Zhou more than expected).

Fields of papers citing papers by Kaiqian Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaiqian Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaiqian Zhou. The network helps show where Kaiqian Zhou may publish in the future.

Co-authorship network of co-authors of Kaiqian Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Kaiqian Zhou. A scholar is included among the top collaborators of Kaiqian Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaiqian Zhou. Kaiqian Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yunwen, Peipei Wang, Kaiqian Zhou, et al.. (2025). HUWE1‐Mediated Degradation of MUTYH Facilitates DNA Damage and Mitochondrial Dysfunction to Promote Acute Kidney Injury. Advanced Science. 12(13). e2412250–e2412250. 1 indexed citations
2.
Cai, Fangfang, Kaiqian Zhou, Peipei Wang, et al.. (2025). A novel KEAP1 inhibitor, tiliroside, activates NRF2 to protect against acetaminophen-induced oxidative stress and acute liver injury. Hepatology Communications. 9(3). 4 indexed citations
3.
4.
Zhang, Zefan, Minfang Song, Hu L, et al.. (2025). Loss of SGK1 supports metastatic colonization in hepatocellular carcinoma by promoting resistance to T cell-mediated immunity. Journal of Hepatology. 83(2). 397–410. 1 indexed citations
5.
Wang, Peipei, et al.. (2024). Olesoxime protects against cisplatin-induced acute kidney injury by attenuating mitochondrial dysfunction. Biomedical Journal. 48(1). 100730–100730. 1 indexed citations
6.
Cai, Fangfang, et al.. (2024). Tiliroside attenuates acute kidney injury by inhibiting ferroptosis through the disruption of NRF2-KEAP1 interaction. Phytomedicine. 126. 155407–155407. 13 indexed citations
7.
Zhang, Xiangyu, Feiyu Chen, Xinyu Wang, et al.. (2022). Exosome-depleted MiR-148a-3p derived from Hepatic Stellate Cells Promotes Tumor Progression via ITGA5/PI3K/Akt Axis in Hepatocellular Carcinoma. International Journal of Biological Sciences. 18(6). 2249–2260. 45 indexed citations
8.
Wang, Zifei, Yu Zhong, Zefan Zhang, et al.. (2022). Characteristics and Clinical Significance of T-Cell Receptor Repertoire in Hepatocellular Carcinoma. Frontiers in Immunology. 13. 847263–847263. 9 indexed citations
9.
Wu, Liang, Miaomiao Jiang, Yun‐Fan Sun, et al.. (2021). scDPN for High-Throughput Single-Cell CNV Detection to Uncover Clonal Evolution During HCC Recurrence. Genomics Proteomics & Bioinformatics. 19(3). 346–357. 2 indexed citations
10.
Zhang, Xiangyu, Xinyu Wang, Kaiqian Zhou, et al.. (2021). Development and validation of a non-invasive model for diagnosing HBV-related liver cirrhosis. Clinica Chimica Acta. 523. 525–531. 5 indexed citations
11.
Song, Fei, Bo Hu, Jianwen Cheng, et al.. (2020). Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma. Cell Death and Disease. 11(7). 573–573. 87 indexed citations
12.
Wang, Pengxiang, Yun‐Fan Sun, Kaiqian Zhou, et al.. (2020). Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single‐center, retrospective, propensity‐matched study. SHILAP Revista de lepidopterología. 10(3). e137–e137. 34 indexed citations
13.
Zhou, Kaiqian, Yun‐Fan Sun, Jianwen Cheng, et al.. (2020). Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinoma. EBioMedicine. 62. 103107–103107. 34 indexed citations
14.
Yan, Lun‐Jie, et al.. (2020). Lesion-aware convolutional neural network for chest radiograph classification. Clinical Radiology. 76(2). 155.e1–155.e14. 14 indexed citations
15.
Li, Feng, Yuguang Wang, Hua Chen, et al.. (2020). Deep learning-based automated detection of glaucomatous optic neuropathy on color fundus photographs. Graefe s Archive for Clinical and Experimental Ophthalmology. 258(4). 851–867. 68 indexed citations
16.
17.
Yao, Yuhan, Yuancheng Li, Qi Liu, et al.. (2019). Rapid detection of hepatocellular carcinoma metastasis using reverse transcription loop-mediated isothermal amplification. Talanta. 208. 120402–120402. 10 indexed citations
18.
Zhou, Cheng, Yuan‐Fei Peng, Kaiqian Zhou, et al.. (2019). Surgical resection plus radiofrequency ablation for the treatment of multifocal hepatocellular carcinoma. HepatoBiliary Surgery and Nutrition. 8(1). 19–28. 16 indexed citations
19.
Hu, Bo, Jianwen Cheng, Jinwu Hu, et al.. (2019). KPNA3 Confers Sorafenib Resistance to Advanced Hepatocellular Carcinoma via TWIST Regulated Epithelial-Mesenchymal Transition. Journal of Cancer. 10(17). 3914–3925. 28 indexed citations
20.
Zhou, Cheng, Xiangyu Zhang, Yuan‐Fei Peng, et al.. (2019). Surgical Resection plus Radiofrequency Ablation versus Radical Surgery for Hepatocellular Carcinoma: A Propensity Score Matching Analysis. Journal of Cancer. 10(17). 3933–3940. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronald Chan Breakdown of academic impact, for papers by Zijie Wang Breakdown of academic impact, for papers by Chul Koo Cho Breakdown of academic impact, for papers by Huaichao Luo Breakdown of academic impact, for papers by Sheng Li Breakdown of academic impact, for papers by Jin Zhou Breakdown of academic impact, for papers by Fuxing Zhao Breakdown of academic impact, for papers by Zhiqiao Zhang Breakdown of academic impact, for papers by Xiao Hu Breakdown of academic impact, for papers by Panagiota Ravazoula
Rankless by CCL
2026